nach oben

Quality of Life Research

Erschienen in:

01.02.2019

Comparison between the EQ-5D-3L and the SF-6D quality of life (QOL) questionnaires in patients with chronic obstructive pulmonary disease (COPD) undergoing lung volume reduction surgery (LVRS)

verfasst von: Sowmyanarayanan Thuppal, Stephen Markwell, Traves Crabtree, Stephen Hazelrigg

Erschienen in: Quality of Life Research | Ausgabe 7/2019

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config

KI-gestützte Suche

Aus

Abstract

Purpose

Lung volume reduction surgery (LVRS) has been shown to improve lung function, but also improve the overall quality of life (QOL). The aim of this study is to compare two QOL questionnaires-EuroQol Questionnaire (EQ-5D-3L) and 36-item Short Form Health Survey (SF-36) in patients post-LVRS.

Methods

All patients undergoing LVRS for severe chronic obstructive pulmonary disease (COPD) at a single center of excellence were analyzed (n = 94). Baseline demographic and clinical outcomes were characterized. Both EQ-5D-3L and SF-36 questionnaires were administered to all patients at baseline (n = 94) and at the end of 1 year (n = 89) post-surgery. SF-36 was converted to Short Form six-dimensions (SF-6D) using standard algorithm. Correlation, discrimination, responsiveness and differences across the two questionnaires were examined.

Results

The mean age of patients enrolled in the cohort was 66 years. There was significant increase in forced expiratory volume (FEV1, 43%), forced vital capacity (FVC 46%), diffusion capacity (DLCO 15%), 6 min walk distance test (6MWD 21%) and a significant decrease in residual volume (RV 23%) at the end of 1-year follow-up. The overall mean utility index significantly improved for both SF-6D and EQ-5D-3L questionnaires at the end of follow-up (p = 0.0001). However, the magnitude of percentage increase was higher with EQ-5D-3L compared to SF-6D (32% vs. 13%). Stronger correlations confirmed convergent validity at the end of 1-year follow-up between similar domains. Both questionnaires failed to discriminate between different levels of disease severity post-LVRS in patients with severe COPD.

Conclusions

Both questionnaires responded similarly in patients with COPD post-LVRS. Combining results from QOL questionnaire(s) along with symptoms of disease and history of exacerbation may be a possible solution for identifying disease severity in old and sick patients unwilling/unable to come to hospital for a pulmonary function test post-LVRS.

Vorheriger Artikel Obesity phenotype and patient-reported outcomes in moderate and severe chronic kidney disease: a cross-sectional study from the CKD-REIN cohort study

Nächster Artikel Comparative study of PROMISⓇ self-efficacy for managing chronic conditions across chronic neurologic disorders

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 102.000 Bücher
über 537 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 340 Zeitschriften

aus folgenden Fachgebieten:

Bauwesen + Immobilien
Business IT + Informatik
Finance + Banking
Management + Führung
Marketing + Vertrieb
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Centers for Disease Control and Prevention. (2012). Chronic obstructive pulmonary disease among adults–United States, 2011. Morbidity and Mortality Weekly Report, 61(46), 938–943.

Wheaton, A. G., Cunningham, T. J., Ford, E. S., Croft, J. B., Centers for Disease C., & Prevention (2015). Employment and activity limitations among adults with chronic obstructive pulmonary disease–United States, 2013. Morbidity and Mortality Weekly Report, 64(11), 289–295.PubMedPubMedCentral

Centers for Diseasr Control and Prevention. (2017). Chronic obstructive pulmonary disease. Retrieved May 31, 2018, from https://www.cdc.gov/copd/index.html#6.

Wacker, M. E., Jorres, R. A., Karch, A., Wilke, S., Heinrich, J., Karrasch, S., Koch, A., Schulz, H., Watz, H., Leidl, R., Vogelmeier, C., Holle, R., & Consortium, C. (2016). Assessing health-related quality of life in COPD: Comparing generic and disease-specific instruments with focus on comorbidities. BMC Pulmonary Medicine, 16(1), 70.CrossRefPubMedPubMedCentral

Goldstein, R. S., Todd, T. R., Guyatt, G., Keshavjee, S., Dolmage, T. E., van Rooy, S., Krip, B., Maltais, F., LeBlanc, P., Pakhale, S., & Waddell, T. K. (2003). Influence of lung volume reduction surgery (LVRS) on health related quality of life in patients with chronic obstructive pulmonary disease. Thorax, 58(5), 405–410.CrossRefPubMedPubMedCentral

Huang, W., Wang, W. R., Deng, B., Tan, Y. Q., Jiang, G. Y., Zhou, H. J., & He, Y. (2011). Several clinical interests regarding lung volume reduction surgery for severe emphysema: Meta-analysis and systematic review of randomized controlled trials. Journal of Cardiothoracic Surgery, 6, 148.CrossRefPubMedPubMedCentral

Kaplan, R. M., Sun, Q., & Ries, A. L. (2015). Quality of well-being outcomes in the National Emphysema Treatment Trial. Chest, 147(2), 377–387.CrossRefPubMed

Beer, T. M., Miller, K., Tombal, B., Cella, D., Phung, D., Holmstrom, S., Ivanescu, C., Skaltsa, K., & Naidoo, S. (2017). The association between health-related quality-of-life scores and clinical outcomes in metastatic castration-resistant prostate cancer patients: Exploratory analyses of AFFIRM and PREVAIL studies. European Journal of Cancer, 87, 21–29.CrossRefPubMed

Vickers, M. M., Lee, C., Tu, D., Wheatley-Price, P., Parulekar, W., Brundage, M. D., Moore, M. J., Au, H., O’Callaghan, C. J., Jonker, D. J., Ringash, J., & Goldstein, D. (2016). Significance of baseline and change in quality of life scores in predicting clinical outcomes in an international phase III trial of advanced pancreatic cancer: NCIC CTG PA.3. Pancreatology, 16(6), 1106–1112.CrossRefPubMed

10.

Brazier, J., Roberts, J., Tsuchiya, A., & Busschbach, J. (2004). A comparison of the EQ-5D and SF-6D across seven patient groups. Health Economics, 13(9), 873–884.CrossRefPubMed

11.

Chen, J., Wong, C. K., McGhee, S. M., Pang, P. K., & Yu, W. C. (2014). A comparison between the EQ-5D and the SF-6D in patients with chronic obstructive pulmonary disease (COPD). PLoS ONE, 9(11), e112389.CrossRefPubMedPubMedCentral

12.

Lamers, L. M., Bouwmans, C. A., van Straten, A., Donker, M. C., & Hakkaart, L. (2006). Comparison of EQ-5D and SF-6D utilities in mental health patients. Health Economics, 15(11), 1229–1236.CrossRefPubMed

13.

McCrone, P., Patel, A., Knapp, M., Schene, A., Koeter, M., Amaddeo, F., Ruggeri, M., Giessler, A., Puschner, B., & Thornicroft, G. (2009). A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia. The Journal of Mental Health Policy and Economics, 12(1), 27–31.PubMed

14.

Pickard, A. S., Yang, Y., & Lee, T. A. (2011). Comparison of health-related quality of life measures in chronic obstructive pulmonary disease. Health and Quality of Life Outcomes, 9, 26.CrossRefPubMedPubMedCentral

15.

Brooks, R. (1996). EuroQol: The current state of play. Health Policy, 37(1), 53–72.CrossRefPubMed

16.

Rabin, R., & de Charro, F. (2001). EQ-5D: A measure of health status from the EuroQol Group. Annals of Medicine, 33(5), 337–343.CrossRefPubMed

17.

Dolan, P. (1997). Modeling valuations for EuroQol health states. Medical Care, 35(11), 1095–1108.CrossRefPubMed

18.

User’s Manual for the Medical Outcomes Study (MOS). (1995). Core measures of health-related quality of life. Santa Monica: RAND Corporation.

19.

Brazier, J., Roberts, J., & Deverill, M. (2002). The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics, 21(2), 271–292.CrossRefPubMed

20.

Cohen, J. (1992). A power primer. Psychological Bulletin, 112(1), 155–159.CrossRefPubMed

21.

Global Initiative for COPD. (2017). Pocket guide to COPD diagnosis, management, and prevention: A guide for health care professionals.

22.

DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988). Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics, 44(3), 837–845.CrossRefPubMed

23.

Vestbo, J., Hurd, S. S., & Rodriguez-Roisin, R. (2012). The 2011 revision of the global strategy for the diagnosis, management and prevention of COPD (GOLD)—why and what? The Clinical Respiratory Journal, 6(4), 208–214.CrossRefPubMed

24.

Moayeri, F., Hsueh, Y. S., Clarke, P., Hua, X., & Dunt, D. (2016). Health state utility value in chronic obstructive pulmonary disease (COPD); the challenge of heterogeneity: A systematic review and meta-analysis. COPD, 13(3), 380–398.CrossRefPubMed

25.

van Stel, H. F., & Buskens, E. (2006). Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease. Health and Quality of Life Outcomes, 4, 20.CrossRefPubMedPubMedCentral

26.

Ringbaek, T., Brondum, E., Martinez, G., & Lange, P. (2008). EuroQoL in assessment of the effect of pulmonary rehabilitation COPD patients. Respiratory Medicine, 102(11), 1563–1567.CrossRefPubMed

27.

Kularatna, S., Byrnes, J., Chan, Y. K., Ski, C. F., Carrington, M., Thompson, D., Stewart, S., & Scuffham, P. A. (2017). Comparison of the EQ-5D-3L and the SF-6D (SF-12) contemporaneous utility scores in patients with cardiovascular disease. Quality of Life Research, 26(12), 3399–3408.CrossRefPubMed

28.

Rowen, D., Young, T., Brazier, J., & Gaugris, S. (2012). Comparison of generic, condition-specific, and mapped health state utility values for multiple myeloma cancer. Value Health, 15(8), 1059–1068.CrossRefPubMed

29.

Brazier, J., Rowen, D., Tsuchiya, A., Yang, Y., & Young, T. A. (2011). The impact of adding an extra dimension to a preference-based measure. Social Science & Medicine, 73(2), 245–253.CrossRef

30.

Payakachat, N., Ali, M. M., & Tilford, J. M. (2015). Can The EQ-5D detect meaningful change? A Systematic Review. Pharmacoeconomics, 33(11), 1137–1154.PubMed

Titel: Comparison between the EQ-5D-3L and the SF-6D quality of life (QOL) questionnaires in patients with chronic obstructive pulmonary disease (COPD) undergoing lung volume reduction surgery (LVRS)
verfasst von: Sowmyanarayanan Thuppal
Stephen Markwell
Traves Crabtree
Stephen Hazelrigg
Publikationsdatum: 01.02.2019
Verlag: Springer International Publishing
Erschienen in: Quality of Life Research / Ausgabe 7/2019
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-019-02123-x

Springer Professional

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu Ihrer Lizenz zu erhalten.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Springer Professional "Wirtschaft"

Weitere Artikel der Ausgabe 7/2019

Quality of life of cancer patients living in Trinidad and Tobago

Ethnic background and children’s oral health-related quality of life

Obesity phenotype and patient-reported outcomes in moderate and severe chronic kidney disease: a cross-sectional study from the CKD-REIN cohort study

Comparative study of PROMISⓇ self-efficacy for managing chronic conditions across chronic neurologic disorders

Predicting quality of life during and post detention in incarcerated juveniles

Patterns, trends and methodological associations in the measurement and valuation of childhood health utilities